To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Merck KGaA v. Integra Lifesciences I, Ltd.
Merck KGaA, Petitioner v. Integra Lifesciences I, Ltd., et al., 545 U.S. 193 (2005), is a United States Supreme Court case with ramifications for patent law. The dispute dates to approximately 1996 and centers on a federal law known as the "FDA safe harbor". Additional recommended knowledgeSee also
References
|
|||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Merck_KGaA_v._Integra_Lifesciences_I,_Ltd.". A list of authors is available in Wikipedia. |
- Methamphetamine/Ecstasy Detection Patent & Product Launch
- Roche exercises option on compounds from collaboration with Siena Biotech - New molecules could offer innovative treatment approach for Alzheimer’s Disease
- Lichen
- Transcription Factor Scan Identifies Genetic Cause for Inherited Blindness. - Multinational team effort of Regensburg´s Institute of Human Genetics, Washington University in St. Louis, other partners, and Genomatix elucidated a transcriptional network in photoreceptors and thereby identified a novel retinal disease gene
- Haplogroup_E3a_(Y-DNA)